Imaging mass spectrometry reveals heterogeneity of proliferation and metabolism in atherosclerosis
Christelle Guillermier(Brigham and Women's Hospital), Jonathan D. Brown(Vanderbilt University), Sean Doherty(Vanderbilt University Medical Center), Vladimir R. Babaev(Vanderbilt University Medical Center), Adam Whitney(Brigham and Women's Hospital), MacRae F. Linton(Vanderbilt University), Matthew L. Steinhauser(Brigham and Women's Hospital)
Cited by 25
Related Papers
Current Perspectives on Statins
|Circulation|2000|1.2k
Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2
|Nature|2007|732
Lack of macrophage fatty-acid–binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis
|Nature Medicine|2001|692